CAY10505 is a phosphatidylinositol 3-kinase- inhibitor , was found to significantly improve acetylcholine-induced endothelium dependent relaxation, serum nitrate and (or) nitrite level, glutathione level, and the vascular endothelial lining in hypertensive rats. CAY10505 , may improve hypertension-associated vascular endothelial dysfunction. Inhibition of PI3K might be a useful approach in the therapeutics of vascular endothelium dysfunction.
For research use only. We do not sell to patients.
Name | CAY10505 |
---|---|
Iupac Chemical Name | (E)-5-((5-(4-fluorophenyl)furan-2-yl)methylene)thiazolidine-2,4-dione |
Synonyms | CAY10505; CAY 10505; CAY10505 |
Molecular Formula | C14H8FNO3S |
Molecular Weight | 289.28 |
Smile | FC1=CC=C(C=C1)C1=CC=C(O1)\C=C\1/C(NC(S1)=O)=O |
InChiKey | UFBTYTGRUBUUIL-KPKJPENVSA-N |
InChi | InChI=1S/C14H8FNO3S/c15-9-3-1-8(2-4-9)11-6-5-10(19-11)7-12-13(17)16-14(18)20-12/h1-7H,(H,16,17,18)/b12-7+ |
CAS Number | 1218777-13-9 |
Related CAS |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | Solid powder |
---|---|
Purity | 98% by HPLC |
Storage | -20 ºC for 3 years |
Solubility | Soluble in DMSO |
Handling | |
Shipping Condition | Shipped under ambient temperature |
HS Code |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |